New HIV prevention strategy shows promise for At-Risk men in africa

NCT ID NCT02626286

Completed Prevention Sponsor: ANRS, Emerging Infectious Diseases Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a quarterly HIV prevention program is practical and helpful for men who have sex with men in four African countries. Over 800 men received regular check-ups, STI testing and treatment, counseling, and condoms. The goal was to see if this approach could lower HIV rates in this group and their partners.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: quarterly preventive care package (check-ups, STI treatment, counseling, condoms)
What this could lead to: If successful, this approach could help reduce HIV infections among men who have sex with men and their partners in sub-Saharan Africa.
What could go wrong: This is a feasibility study, not a large-scale trial. Results may not apply to other regions or populations, and the program's impact on HIV rates is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease Homosexuality

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV INFECTION

Contacts and locations

Locations

Centre Oasis, Association African Solidarité (AAS)

Ouagadougou, Burkina Faso
Clinique de Confiance, Espace Confiance

Abidjan, Côte d’Ivoire
Clinique des Halles, ARCAD-SIDA

Bamako, Mali
Espoir vie Togo

Lomé, Togo

More trials for these conditions

Other studies related to the condition(s) this trial covers.